Thursday 25th February 2021
|Text too small?|
In November 2020 Gentrack Group Limited (NZX/ASX: GTK) (“Gentrack”) advised that it expected that the full year EBITDA run rate for FY21 would be well below that of the H2 FY20 run rate and that FY21 profitability may be reduced closer to break-even depending on the levels of future product investment and other factors.
Gentrack now provides the following outlook update:
•FY21 revenues are expected to be close to or slightly ahead of FY20 revenues of $100.5m
•FY21 EBITDA is expected to be around $5m on the basis that research and development (R&D) costs are expensed
•Incremental R&D costs are expected to be ~$3m/quarter from Q3 FY21
•The company expects to be net cashflow positive in FY21, building on the $16.8m of net cash reported at 30th September 2020.
Profit and cashflow are expected to be weighted to H1 FY21 given the incremental R&D spend forecast for H2.
Please see the link below for details:
No comments yet
Fonterra provides milk price, performance, strategy update
Revised Chatham announcement concerning PDAC
23rd June 2022 Morning Report
Greenfern Industries attains important industry certificati
Appointment of Group General Manager Sales & Service
NZME confirms Google agreements
FBU Investor Day FY22 EBIT guidance c.$750m reiterated
Chatham Reports on Multiple Milestones Achieved at PDAC
22nd June 2022 Morning Report
21st June 2022 Morning Report